ExpreS2ion Biotech Holding

1,66 SEK

0,00%

Mindre end 1K følgere

EXPRS2

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for ExpreS2ion Biotech Holding

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning0,63,01,31,50,40,43,71,0
EBITDA-19,3-104,2-12,3-11,3-9,4-9,8-42,8-11,6
EBIT-19,7-67,7-12,7-11,7-9,7-10,2-44,3-11,9
EBIT-%-3.283,3 %-2.249,2 %-951,9 %-758,4 %-2.760,9 %-2.340,2 %-1.210,6 %-1.150,4 %
Overskud før skat-19,4-44,6-14,0-11,5-9,8-10,0-44,2-12,1
Netto indkomst-15,6-36,4-11,4-10,0-8,4-8,2-38,1-9,6